Vertex Pharmaceuticals Inc
(LTS:0QZU)
$
469.72
-2.9 (-0.61%)
Market Cap: 120.95 Bil
Enterprise Value: 111.50 Bil
PE Ratio: 30.42
PB Ratio: 6.53
GF Score: 89/100 - Q1 2024 Vertex Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2024$400.71Earnings
- Vertex Pharmaceuticals Inc at TD Cowen Health Care Conference TranscriptMar 05, 2024
- Q4 2023 Vertex Pharmaceuticals Inc Earnings Call TranscriptFeb 05, 2024$429.41 (+0.44%)Earnings
- Vertex Pharmaceuticals Inc VX-548 Phase 3 Results in Acute Pain Conference Call TranscriptJan 30, 2024
- Vertex Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Vertex Pharmaceuticals Inc to Host Conference Call TranscriptDec 13, 2023
- Vertex Pharmaceuticals Inc at Jefferies London Healthcare Conference TranscriptNov 14, 2023
- Vertex Pharmaceuticals Inc at UBS BioPharma Conference TranscriptNov 09, 2023
- Q3 2023 Vertex Pharmaceuticals Inc Earnings Call TranscriptNov 06, 2023$384.59 (+1.97%)Earnings
- Vertex Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Vertex Pharmaceuticals Inc Earnings Call TranscriptAug 01, 2023$346.76 (-1.50%)Earnings
- Vertex Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Vertex Pharmaceuticals Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Vertex Pharmaceuticals Inc Earnings Call TranscriptMay 01, 2023$343.58Earnings
- Vertex Pharmaceuticals Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- Q4 2022 Vertex Pharmaceuticals Inc Earnings Call TranscriptFeb 07, 2023$305.11 (-0.60%)Earnings
- Vertex Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Vertex Pharmaceuticals Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 30, 2022
- Vertex Pharmaceuticals Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 Vertex Pharmaceuticals Inc Earnings Call TranscriptOct 27, 2022$288.98 (-7.23%)Earnings
- Vertex Pharmaceuticals Inc at Wells Fargo Healthcare Conference TranscriptSep 09, 2022
- Q2 2022 Vertex Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022$276.11 (-0.30%)Earnings
- Vertex Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Q1 2022 Vertex Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2022$265.94 (-1.25%)Earnings
- Vertex Pharmaceuticals Inc at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Q4 2021 Vertex Pharmaceuticals Inc Earnings Call TranscriptJan 26, 2022$228.16 (+0.99%)Earnings
- Vertex Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Vertex Pharmaceuticals Inc to Discuss VX-147 Phase 2 Clinical Results Call TranscriptDec 01, 2021
- Q3 2021 Vertex Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2021$181.59 (-1.99%)Earnings
- Vertex Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Q2 2021 Vertex Pharmaceuticals Inc Earnings Call TranscriptJul 29, 2021$200.15 (-0.76%)Earnings
- Vertex Pharmaceuticals Inc to Discuss VX-864 Phase 2 Results and Alpha-1-Antitrypsin Deficiency (AATD) Program Update Call TranscriptJun 10, 2021
- Vertex Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Vertex Pharmaceuticals Inc Earnings Call TranscriptApr 29, 2021$210.9 (-1.24%)Earnings
- Vertex Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Q4 2020 Vertex Pharmaceuticals Inc Earnings Call TranscriptFeb 01, 2021$229.57 (+0.64%)Earnings
- Vertex Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- CRISPR Therapeutics AG and Vertex Pharmaceuticals Inc to Host AG Phase 1/2 CTX001â„¢ Investor Update TranscriptDec 09, 2020
- Vertex Pharmaceuticals Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 19, 2020
- Q3 2020 Vertex Pharmaceuticals Inc Earnings Call TranscriptOct 29, 2020$206.09 (-2.65%)Earnings
- Q2 2020 Vertex Pharmaceuticals Inc Earnings Call TranscriptJul 30, 2020$279.67Earnings
- Q1 2020 Vertex Pharmaceuticals Inc Earnings Call TranscriptApr 29, 2020$254.75Earnings
- Q4 2019 Vertex Pharmaceuticals Inc Earnings Call TranscriptJan 30, 2020$230.83 (-0.72%)Earnings
- Vertex Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Vertex Pharmaceuticals Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q3 2019 Vertex Pharmaceuticals Inc Earnings Call TranscriptOct 30, 2019$198.46 (+3.01%)Earnings
- Vertex Pharmaceuticals Inc at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Q2 2019 Vertex Pharmaceuticals Inc Earnings Call TranscriptJul 31, 2019$166.49 (-1.41%)Earnings
- Q1 2019 Vertex Pharmaceuticals Inc Earnings Call TranscriptApr 30, 2019$170.34 (-1.77%)Earnings
- Q4 2018 Vertex Pharmaceuticals Inc Earnings Call TranscriptFeb 05, 2019$190.92Earnings
Vertex Pharmaceuticals Inc at Bank of America Global Healthcare Conference Transcript
May 09, 2023 / 04:20PM GMT
Release Date Price:
$343.34
(-1.01%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Welcome to the first morning of the BofA Healthcare Conference. I'm Geoff Meacham. I'm the senior biopharma analyst here, and we're thrilled to have Vertex Pharmaceuticals in the big room, hopefully no protesting this year. But on behalf of Vertex, we have Charlie Wagner, Executive VP and CFO; and David Altshuler, who is CSO and EVP of Global Research. Guys, welcome.
David M. Altshuler
Vertex Pharmaceuticals Incorporated - Executive VP of Global Research & Chief Scientific Officer
Thank you.
Charles F. Wagner
Vertex Pharmaceuticals Incorporated - Executive VP & CFO
Yes, Geoff, thank you. Thanks for hosting.
Geoffrey Christopher Meacham;Charles F. Wagner
BofA Securities, Research Division - Research Analyst;Vertex
So Charlie, you want to disclose the quarter, just give us a little bit of a high level, and then we'll get into some questions.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)